Study finds hidden mutation rates may shape cancer risk

A recent study conducted by researchers at City of Hope and TGen has revealed significant variations in mutation rates among healthy individuals, which may contribute to cancer risk. The research, published in Cancer Research, compares the number of mutations in organs from both healthy individuals and those with cancer, finding that cancer cells contain approximately four times as many DNA mutations as normal cells.

Surprisingly, some apparently healthy participants in the study had mutation counts similar to those typically found in cancer patients, suggesting that these individuals may be at a higher risk of developing cancer. This finding challenges previous assumptions about cancer risk and opens up new avenues for cancer risk assessment and prevention strategies.

The study, led by Dr. Cristian Tomasetti, analyzed DNA from seven human organs: bladder, colon, esophagus, liver, lung, prostate, and stomach. By examining publicly available whole-genome and whole-exome sequencing data from hundreds of normal tissue samples and thousands of cancer samples, the researchers were able to identify substantial differences in mutation burdens across organs.

These differences were found to be consistent across all organs studied, with cancer cells consistently showing a statistically significant increase in mutation burden compared to healthy tissue.

A key finding of the study is the role of the "tail hypothesis" in explaining the elevated mutation burden. This hypothesis suggests that some individuals accumulate mutations at a higher rate in their tissues, leading to increased cancer risk. Even after accounting for factors like age, the study revealed that some healthy individuals had up to eight times more mutations than others, demonstrating that mutation rates vary widely among seemingly healthy individuals.

This variation in mutation accumulation could help explain why some people are more prone to developing cancer than others.